Log in
Enquire now
‌

US Patent 10258614 Compositions and methods for treating schizophrenia

Patent 10258614 was granted and assigned to Minerva Neurosciences on April, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Minerva Neurosciences
Minerva Neurosciences
0
Current Assignee
Minerva Neurosciences
Minerva Neurosciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
102586140
Patent Inventor Names
Sandra Werner0
Nadine Noel0
Remy Luthringer0
Date of Patent
April 16, 2019
0
Patent Application Number
156510650
Date Filed
July 17, 2017
0
Patent Citations Received
0
‌
US Patent 10799493 Compositions and methods for treating schizophrenia
‌
US Patent 11464744 Gastro-resistant controlled release oral dosage forms
Patent Primary Examiner
‌
Raymond J. Henley, III
0
Patent abstract

The disclosure provides a novel polymorph of Compound (I):

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10258614 Compositions and methods for treating schizophrenia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.